Pursuit's Take
GAO identified 23 practices for addressing prescription drug fraud, waste, and abuse that fall within three categories based on GAO’s Fraud Prevention Framework—prevention, detection and monitoring, and investigation and prosecution.
The Department of Health and Human Services’ (HHS) Centers for Medicare & Medicaid Services’ (CMS) activities to address prescription drug fraud, waste, and abuse in the Medicare Part D prescription drug program reflect 14 of these 23 identified practices, some of which are in multiple categories, and the agency plans to implement 3 additional practices.
Read the full report